Log in Register

Login to your account

Username
Password *
Remember Me

Create an account

Fields marked with an asterisk (*) are required.
Name
Username
Password *
Verify password *
Email *
Verify email *
Captcha *

Articles

JCI Editorials 2013

JCI Editorials/Perspectives/Commentaries/Science in Medicine 2013

ISSUE PERSPECTIVES/EDITORIALS/COMMENTARIES
2 January 2013 Vol.123;1

Commentaries

(1)The benefits of restraint: a pivotal role for IL-13 in hepatic glucose homeostasis 

(2)A heartfelt response: new thyroid hormone–sensitive neurons in the hypothalamus

1 February 2013 Vol.123;2
 

Science in Medicine

(1)Alzheimer’s disease and insulin resistance: translating basic science into clinical applications 

1 March 2013 Vol.123;3
 

(1)Tempus fugit 

1 April 2013 Vol.123;4
 

(1)A mitochondrial bioenergetic etiology of disease 

1 May 2013 Vol.123;5
 Science in Medicine

(1)Thinking laterally about neurodegenerative proteinopathies 

3 June 2013 Vol.123;6
 Science in Medicine

(1)Iron regulation by hepcidin 

 
1 July 2013 Vol.123;7

 Science in Medicine

(1) AMPK, insulin resistance, and the metabolic syndrome

 

 
1 August 2013 Vol.123;8

 

Commentaries

(1) Rapamycin, anti-aging, and avoiding the fate of Tithonus 

(2) The future of molecular chaperones and beyond

(3) Chronic THC intake modifies fundamental cerebellar functions

 
1 September 2013 Vol.123;9

 

Commentaries

(1) Unshackling caspase-7 for cancer therapy 

(2) Donor-associated malignancy in kidney transplant patients

(3) Factor V, tissue factor pathway inhibitor, and east Texas bleeding disorder

(4) A “Tric” to tighten cell-cell junctions in the cochlea for hearing

 
1 October  2013 Vol.123;10

 

Review

(1)Pharmacological agents currently in clinical trials for disorders in neurogastroenterology

(2)Emerging concepts in immunity to hepatitis C virus infection

 
1 November  2013 Vol.123;11

 

Review

(1)Deep brain stimulation (DBS) at the interface of neurology and psychiatry

(2)The genomics of schizophrenia: update and implications

 
1 December  2013 Vol.123;12

 

Review

(1)Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype–targeted drugs